John K Clarke's Net Worth
$442 Million
Who is John K Clarke?
John K Clarke has an estimated net worth of $442 Million. This is based on reported shares across multiple companies, which include ALNYLAM PHARMACEUTICALS, INC., VISICU INC, Sirtris Pharmaceuticals, Inc., Verastem, Inc., aTYR PHARMA INC, MOMENTA PHARMACEUTICALS INC, CUBIST PHARMACEUTICALS INC, and ATHENAHEALTH INC.
SEC CIK
John K Clarke's CIK is 0001219015
Past Insider Trading and Trends
2005 was John K Clarke's most active year for acquiring shares with 12 total transactions. John K Clarke's most active month to acquire stocks was the month of May. 2006 was John K Clarke's most active year for disposing of shares, totalling 34 transactions. John K Clarke's most active month to dispose stocks was the month of October. 2012 saw John K Clarke paying a total of $2,548,738.91 for 2,285,569 shares, this is the most they've acquired in one year. In 2008 John K Clarke cashed out on 3,403,923 shares for a total of $40,799,276.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
ATHENAHEALTH INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +80.01% | 2.69M |
$18.00 | -$12,114,000.00 | 6.06M |
Sep 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ALNYLAM PHARMACEUTICALS, INC. (ALNY) Snapshot price: $169.01
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 20
| |||
Form 4
|
—
|
0
|
$63.80 | -$1,095,477.90 | 8.89K |
Scheduled
|
May 31
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 5
| |||
Form 4
|
—
|
0
|
$33.42 | -$1,426,128.90 |
0
|
Scheduled
|
May 21
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
| +799.73% | 1.86M |
—
|
—
| 2.09M |
Jun 3
| |||
Form 4
|
∞
| 232.5K |
—
|
—
| 232.5K |
May 27
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
VISICU INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -3.40M |
$12.00 | -$40,775,076.00 |
0
|
Feb 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 4 - Jul 26
| |||
Form 4
| -10.36% | -387.00K |
$10.04 | -$3,884,381.80 | 3.35M |
Nov 30
| |||
Form 4
| -0.31% | -31.50K |
$10.04 | -$316,200.00 | 10.23M |
Nov 16
| |||
Form 4
|
∞
| 3.77M |
—
|
—
| 3.77M |
Apr 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Sirtris Pharmaceuticals, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 2.07M |
—
|
—
| 2.07M |
May 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Verastem, Inc. (VSTM) Snapshot price: $13.41
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +1.00% | 23.17K |
$9.60 | $222,425.38 | 2.33M |
Jun 12
| |||
Form 4
| +1.10% | 25K |
$9.22 | $230,477.50 | 2.31M |
Jun 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 4
| |||
Form 4
| +1.11% | 25K |
$9.74 | $243,375.00 | 2.28M |
Scheduled
|
May 13
| ||
Form 4
| +0.45% | 10K |
$9.66 | $96,622.00 | 2.26M |
Scheduled
|
May 1
| ||
Form 4
| +0.25% | 5.63K |
$9.50 | $53,488.87 | 2.25M |
Apr 17
| |||
Form 4
| +0.28% | 6.19K |
$7.87 | $48,738.91 | 2.24M |
Scheduled
|
Dec 18
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 6
| |||
Form 4
|
∞
| 2.23M |
$10.00 |
—
| 2.23M |
Feb 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||